Cornell Pochily Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
8,019
+1
+0% +$117 0.28% 83
2026
Q1
$964K Sell
8,018
-12
-0.1% -$1.39K 0.28% 75
2025
Q4
$845K Sell
8,030
-115
-1% -$10.8K 0.25% 81
2025
Q3
$684K Sell
8,145
-2,524
-24% -$208K 0.2% 99
2025
Q2
$845K Buy
10,669
+698
+7% +$55.5K 0.28% 82
2025
Q1
$895K Buy
9,971
+550
+6% +$51.4K 0.31% 81
2024
Q4
$937K Buy
9,421
+585
+7% +$60.3K 0.33% 76
2024
Q3
$1M Sell
8,836
-335
-4% -$39.8K 0.35% 75
2024
Q2
$1.14M Buy
9,171
+360
+4% +$46.4K 0.43% 60
2024
Q1
$1.16M Buy
8,811
+139
+2% +$17.1K 0.46% 60
2023
Q4
$945K Sell
8,672
-4,051
-32% -$421K 0.39% 74
2023
Q3
$1.31M Sell
12,723
-800
-6% -$86.2K 0.57% 52
2023
Q2
$1.56M Sell
13,523
-1,832
-12% -$208K 0.64% 45
2023
Q1
$1.63M Sell
15,355
-49
-0.3% -$5.29K 0.7% 39
2022
Q4
$1.71M Sell
15,404
-336
-2% -$34.3K 0.76% 34
2022
Q3
$1.36M Sell
15,740
-201
-1% -$17.9K 0.59% 39
2022
Q2
$1.45M Buy
15,941
+146
+0.9% +$12.9K 0.65% 44
2022
Q1
$1.3M Buy
15,795
+805
+5% +$63.5K 0.5% 57
2021
Q4
$1.15M Buy
14,990
+368
+3% +$29.3K 0.45% 64
2021
Q3
$1.1M Buy
14,622
+619
+4% +$47.1K 0.48% 59
2021
Q2
$1.09M Buy
14,003
+292
+2% +$21.7K 0.48% 58
2021
Q1
$1.01M Buy
13,711
+706
+5% +$52.1K 0.48% 57
2020
Q4
$1.01M Buy
13,005
+223
+2% +$17.1K 0.49% 55
2020
Q3
$1.01M Sell
12,782
-464
-4% -$36.3K 0.58% 44
2020
Q2
$977K Buy
13,246
+234
+2% +$17.6K 0.61% 43
2020
Q1
$955K Buy
13,012
+519
+4% +$40.8K 0.71% 39
2019
Q4
$1.08M Sell
12,493
-173
-1% -$14.2K 0.65% 43
2019
Q3
$1.02M Buy
12,666
+58
+0.5% +$4.65K 0.65% 44
2019
Q2
$1.01K Buy
12,608
+1,874
+17% +$143K 0.25% 53
2019
Q1
$851K Sell
10,734
-1,906
-15% -$143K 0.58% 48
2018
Q4
$921K Buy
12,640
+1,218
+11% +$86K 0.6% 47
2018
Q3
$773K Sell
11,422
-902
-7% -$57.5K 0.52% 54
2018
Q2
$713K Sell
12,324
-1,236
-9% -$69.7K 0.49% 58
2018
Q1
$704K Buy
13,560
+224
+2% +$12.1K 0.5% 62
2017
Q4
$716K Buy
+13,336
New +$739K 0.46% 68

Other funds holding MRK

Cornell Pochily Investment Advisors's MRK Position: Q2 2026 in Review

Cornell Pochily Investment Advisors increased its Merck (MRK) stake by 0.01% in Q2 2026, buying an estimated $117 and bringing the position to 8,019 shares worth $1.03M. The position accounts for 0.28% of the portfolio, ranked #83.

Cornell Pochily Investment Advisors first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.71M in Q4 2022. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cornell Pochily Investment Advisors held 8,019 shares of Merck worth $1.03M as of Q2 2026.
  • Cornell Pochily Investment Advisors bought 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.28% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #83 holding.
  • Cornell Pochily Investment Advisors first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
  • Cornell Pochily Investment Advisors's Merck position peaked at $1.71M in Q4 2022.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.